×
Accedi
Iniziamo
Travel
Technology
Sports
Marketing
Education
Career
Social Media
+ Esplora tutte le categorie
Report -
BELIMUMAB Lupus eritematoso sistémico · Lupus eritematoso sistémico (LES) 2 1.- IDENTIFICACIÓN DEL FÁRMACO Y AUTORES DEL INFORME Fármaco: Belimumab. Indicación clínica solicitada:
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Please pass captcha verification before submit form